Improving Understanding and Acceptance of Biosimilars in the United States

Reports on biosimilar medicines


How to promote confidence in biosimilars, in various North American health organizations
A Samsung Bioepis report carried out in different health organizations in the United States highlights the current challenges for improving the adoption of biosimilars.

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE